TABLE 4.
Sp. | DS | CA | RA | Sal B | Sal A | DT-1 | TS-1 | CT | TS-IIA | TP | TTS |
GLF | 0.63 ± 0.15 | 0.32 ± 0.16 | 11.52 ± 1.38 | 62.68 ± 5.43** | 0.88 ± 0.06** | 0.17 ± 0.09 | 0.03 ± 0.01 | 2.96 ± 2.1 | 2.01 ± 1.12 | 76.04 ± 6.74** | 5.17 ± 3.31 |
GLT | 0.5 ± 0.1 | 0.48 ± 0.18* | 8.53 ± 3 | 46.93 ± 9.62 | 0.75 ± 0.15 | 0.42 ± 0.14** | 0.03 ± 0.01 | 5.89 ± 2.82 | 2.6 ± 1.07 | 57.17 ± 12.37 | 8.93 ± 4.02 |
SEC | 0.6 ± 0.12 | 0.23 ± 0.01 | 8.94 ± 2.84 | 50.68 ± 6.7 | 0.67 ± 0.08 | 0.13 ± 0.06 | 0.03 ± 0.02 | 3.51 ± 3.58 | 2 ± 1.62 | 61.13 ± 9.33 | 5.67 ± 5.24 |
FUG | 0.22 ± 0.01** | 0.34 ± 0.08 | 2.85 ± 1.51** | 25.64 ± 8.84** | 0.27 ± 0.14** | 0.22 ± 0.08 | 0.04 ± 0.01** | 4.5 ± 1.02 | 3.24 ± 0.6 | 29.32 ± 10.35** | 8 ± 0.96 |
RHM | 0.34 ± 0.08* | 0.22 ± 0.02 | 9.2 ± 1.9 | 54.17 ± 8.16* | 0.67 ± 0.14 | 0.12 ± 0.03 | 0.03 ± 0 | 1.75 ± 0.4 | 1.4 ± 0.3 | 64.6 ± 10.24 | 3.3 ± 0.67 |
AMG | 0.48 ± 0.23 | 0.22 ± 0.06 | 6.77 ± 1.51* | 51.02 ± 2.79** | 0.6 ± 0.1 | 0.11 ± 0.01 | 0.02 ± 0.01 | 2.58 ± 0.81 | 1.8 ± 0.62 | 59.09 ± 2.82 | 4.52 ± 1.39 |
ACL | 0.67 ± 0.23 | 0.41 ± 0.14* | 13.23 ± 1.18* | 57.41 ± 11.52* | 0.9 ± 0.24* | 0.21 ± 0.03 | 0.05 ± 0.01** | 2.39 ± 0.49 | 1.45 ± 0.45 | 72.62 ± 12.79* | 4.1 ± 0.94 |
ACT | 0.39 ± 0.06** | 0.13 ± 0.03 | 7.58 ± 0.53 | 42.09 ± 3.27 | 0.72 ± 0.08 | 0.21 ± 0.08 | 0.04 ± 0.01** | 3.95 ± 1.05 | 2.17 ± 0.64 | 50.92 ± 3.68 | 6.36 ± 1.67 |
NM | 0.56 ± 0.1 | 0.21 ± 0.09 | 9.28 ± 2.07 | 42.82 ± 4.17 | 0.62 ± 0.06 | 0.17 ± 0.07 | 0.02 ± 0.01 | 3.18 ± 2.01 | 1.8 ± 1.6 | 53.49 ± 6.4 | 5.18 ± 3.53 |
*Means that there was a significant difference (p < 0.05) between the group compared with NM.
**Means that there was highly significant difference (p < 0.01) between the group compared with NM. Data are mean ± SD (n = 6).